Gerald L. Andriole, Jr., MD, discusses the limitations and successes in the design of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and European Randomized Study of Screening for Prostate Cancer (ERSPC) trials. He also emphasizes the importance of patient selection in PSA screening and utilizing other diagnostic methods.
Read More
Dr. Gerald L. Andriole, MD, reviews the designs, materials, and outcomes of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) and The European Randomized Study of Screening for Prostate Cancer (ERSPC). He distinguishes between legitimate concerns and inappropriate criticisms of the trials. Also, he explains what this means for the practice of PSA testing.
Read More
Gerald L. Andriole, Jr., MD, Barnes-Jewish Hospital, St. Louis, Missouri, discusses whether over...
Read More
Gerald L. Andriole, Jr., MD, Barnes-Jewish Hospital, St. Louis, Missouri, explains the ways to use...
Read More
Gerald L. Andriole, Jr., MD, Washington University, St. Louis, Missouri, discusses ways to improve...
Read More